Navigation Links
Former Thompson lawyer comments on Doyle stem cell executive order

Madison, Wis. - A former chief legal counsel to former Gov. Tommy Thompson said there is nothing inappropriate from a legal standpoint with Gov. Jim Doyle's April 25 executive order on stem cells.

Ray Taffora, a partner in the Madison office of Michael Best & Friedrich, said the governor's powers include the authority to direct state depart......

Full article >>> >
Kanavas has voted with Legislative majorities to enact a comprehensive ban on human cloning, including therapeutic cloning used in research. With therapeutic cloning, an embryo is allowed to develop to the 100 to 200 cell stage, at which point stem cells are isolated for immediate or future use in cell transplantation therapies. The embryo is destroyed in the process of isolating the stem c......

Full article >>> for stem cell products could reach $10 billion over the next ten years, translating into more than 100,000 jobs.

Hamill, however, believes that moral considerations trump economics. "Gov. Doyle now wants us to trust him with inviting 10% of the nation's embryonic stem cell researchers to our state, with no safeguards in place," she said. "The researchers to whom Gov. Doyle has made a ha......

Full article >>>
'"/> By Joe Vanden Plas 05/01/06

Related biology technology :

1. Former Fiserv exec to enter Business Hall of Fame
2. Former astronaut a leader in Wisconsin Spaceport
3. Former NSF director to speak at UW-Madison
4. Former Oracle VP reveals thoughts on benefits of IT
5. Former SGI/Cray Team Develops Products for G5 Platform
6. Thompson in partnership to build ethanol plant
7. Tommy Thompsons Iowa strategy isnt far-fetched
8. Tommy Thompson says capital needed for electronic health records
9. Tommy Thompson joins drug company as advisor
10. Tommy Thompson joins Picis board of directors
11. Tommy Thompson will speak at World Congress on IT next May
Post Your Comments:

(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second ... a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, ... from US2020. , US2020’s mission is to change the trajectory of STEM education ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
(Date:10/9/2017)...  BioTech Holdings announced today identification and patenting ... stem cell therapy prevents limb loss in animal ... that treatment with ProCell resulted in more than ... to standard bone marrow stem cell administration.  Interestingly, ... of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):